# A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye

> **NCT01960010** · PHASE3 · COMPLETED · sponsor: **Mimetogen Pharmaceuticals USA, Inc.** · enrollment: 403 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** MIM-D3 Ophthalmic Solution
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT01960010
- **Lead sponsor:** Mimetogen Pharmaceuticals USA, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 403 (ACTUAL)
- **Last updated:** 2019-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01960010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01960010, "A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01960010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*